{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:40:22Z","timestamp":1794969622407,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58328-x","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T15:27:49Z","timestamp":1743002869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9864-8993","authenticated-orcid":false,"given":"Wanbo","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huicheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjie","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3922-2202","authenticated-orcid":false,"given":"Pengyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7614-7768","authenticated-orcid":false,"given":"Qi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oujia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longchao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0925-5216","authenticated-orcid":false,"given":"Guangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0360-3635","authenticated-orcid":false,"given":"Mingyao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1157-4184","authenticated-orcid":false,"given":"Guocan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-5488","authenticated-orcid":false,"given":"Gong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"58328_CR1","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41564-024-01690-1","volume":"9","author":"B Moss","year":"2024","unstructured":"Moss, B. Understanding the biology of monkeypox virus to prevent future outbreaks. Nat. Microbiol. 9, 1408\u20131416 (2024).","journal-title":"Nat. Microbiol."},{"key":"58328_CR2","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S1473-3099(22)00574-6","volume":"22","author":"GA Poland","year":"2022","unstructured":"Poland, G. A., Kennedy, R. B. & Tosh, P. K. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect. Dis. 22, e349\u2013e358 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"58328_CR3","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1126\/science.add5966","volume":"376","author":"K Kupferschmidt","year":"2022","unstructured":"Kupferschmidt, K. Why monkeypox is mostly hitting men who have sex with men. Science 376, 1364\u20131365 (2022).","journal-title":"Science"},{"key":"58328_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41392-022-01215-4","volume":"7","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Mu, L. & Wang, W. Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal. Transduct. Target Ther. 7, 373 (2022).","journal-title":"Signal. Transduct. Target Ther."},{"key":"58328_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","volume":"71","author":"AK Rao","year":"2022","unstructured":"Rao, A. K. et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the advisory committee on immunization practices - United States, 2022. MMWR Morb. Mortal. Wkly Rep. 71, 734\u2013742 (2022).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"58328_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","volume":"82","author":"JG Rizk","year":"2022","unstructured":"Rizk, J. G., Lippi, G., Henry, B. M., Forthal, D. N. & Rizk, Y. Prevention and treatment of monkeypox. Drugs 82, 957\u2013963 (2022).","journal-title":"Drugs"},{"key":"58328_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4161\/hv.10295","volume":"5","author":"N Paran","year":"2009","unstructured":"Paran, N. & Sutter, G. Smallpox vaccines: new formulations and revised strategies for vaccination. Hum. Vaccin 5, 824\u2013831 (2009).","journal-title":"Hum. Vaccin"},{"key":"58328_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/vaccines6010008","volume":"6","author":"S Melamed","year":"2018","unstructured":"Melamed, S., Israely, T. & Paran, N. Challenges and achievements in prevention and treatment of smallpox. Vaccines 6, 8 (2018).","journal-title":"Vaccines"},{"key":"58328_CR9","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.1016\/j.vaccine.2020.07.018","volume":"38","author":"Y Xiao","year":"2020","unstructured":"Xiao, Y. et al. Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1, or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus. Vaccine 38, 6007\u20136018 (2020).","journal-title":"Vaccine"},{"key":"58328_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","volume":"167","author":"I Gilchuk","year":"2016","unstructured":"Gilchuk, I. et al. Cross-neutralizing and protective human antibody specificities to poxvirus infections. Cell 167, 684\u2013694.e689 (2016).","journal-title":"Cell"},{"key":"58328_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","volume":"84","author":"BL Jacobs","year":"2009","unstructured":"Jacobs, B. L. et al. Vaccinia virus vaccines: past, present and future. Antivir. Res. 84, 1\u201313 (2009).","journal-title":"Antivir. Res."},{"key":"58328_CR12","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1172\/JCI67388","volume":"123","author":"P Gilchuk","year":"2013","unstructured":"Gilchuk, P. et al. Discovering naturally processed antigenic determinants that confer protective T cell immunity. J. Clin. Investig. 123, 1976\u20131987 (2013).","journal-title":"J. Clin. Investig."},{"key":"58328_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.humimm.2008.09.009","volume":"69","author":"M Terajima","year":"2008","unstructured":"Terajima, M. et al. Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans. Hum. Immunol. 69, 815\u2013825 (2008).","journal-title":"Hum. Immunol."},{"key":"58328_CR14","doi-asserted-by":"publisher","first-page":"G21","DOI":"10.1016\/j.vaccine.2009.10.011","volume":"27","author":"A Sette","year":"2009","unstructured":"Sette, A. et al. Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens. Vaccine 27, G21\u2013G26 (2009).","journal-title":"Vaccine"},{"key":"58328_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.20022222","volume":"197","author":"M Terajima","year":"2003","unstructured":"Terajima, M. et al. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses. J. Exp. Med. 197, 927\u2013932 (2003).","journal-title":"J. Exp. Med."},{"key":"58328_CR16","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","volume":"30","author":"GT Szab\u00f3","year":"2022","unstructured":"Szab\u00f3, G. T., Mahiny, A. J. & Vlatkovic, I. COVID-19 mRNA vaccines: platforms and current developments. Mol. Ther. 30, 1850\u20131868 (2022).","journal-title":"Mol. Ther."},{"key":"58328_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","volume":"333","author":"R Verbeke","year":"2021","unstructured":"Verbeke, R., Lentacker, I., De Smedt, S. C. & Dewitte, H. The dawn of mRNA vaccines: the COVID-19 case. J. Control Release 333, 511\u2013520 (2021).","journal-title":"J. Control Release"},{"key":"58328_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","volume":"8","author":"Y Sang","year":"2023","unstructured":"Sang, Y. et al. Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. Signal. Transduct. Target Ther. 8, 172 (2023).","journal-title":"Signal. Transduct. Target Ther."},{"key":"58328_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41628-5","volume":"14","author":"F Hou","year":"2023","unstructured":"Hou, F. et al. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nat. Commun. 14, 5925 (2023).","journal-title":"Nat. Commun."},{"key":"58328_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2192815","volume":"12","author":"RR Zhang","year":"2023","unstructured":"Zhang, R. R. et al. Rational development of multicomponent mRNA vaccine candidates against mpox. Emerg. Microbes Infect. 12, 2192815 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"58328_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2204151","volume":"12","author":"J Zeng","year":"2023","unstructured":"Zeng, J. et al. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge. Emerg. Microbes Infect. 12, 2204151 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"58328_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29140","volume":"95","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice. J. Med. Virol. 95, e29140 (2023).","journal-title":"J. Med. Virol."},{"key":"58328_CR23","doi-asserted-by":"publisher","first-page":"eadg3540","DOI":"10.1126\/scitranslmed.adg3540","volume":"15","author":"AW Freyn","year":"2023","unstructured":"Freyn, A. W. et al. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge. Sci. Transl. Med. 15, eadg3540 (2023).","journal-title":"Sci. Transl. Med."},{"key":"58328_CR24","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani, A. et al. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell 187, 1363\u20131373.e1312 (2024).","journal-title":"Cell"},{"key":"58328_CR25","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.chom.2022.11.003","volume":"30","author":"A Grifoni","year":"2022","unstructured":"Grifoni, A. et al. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans. Cell Host Microbe 30, 1662\u20131670.e1664 (2022).","journal-title":"Cell Host Microbe"},{"key":"58328_CR26","doi-asserted-by":"publisher","first-page":"14567","DOI":"10.1073\/pnas.0800589105","volume":"105","author":"E Hammarlund","year":"2008","unstructured":"Hammarlund, E. et al. Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation. Proc. Natl. Acad. Sci. USA 105, 14567\u201314572 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58328_CR27","doi-asserted-by":"publisher","first-page":"1004804","DOI":"10.3389\/fimmu.2022.1004804","volume":"13","author":"S Aziz","year":"2022","unstructured":"Aziz, S. et al. Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach. Front. Immunol. 13, 1004804 (2022).","journal-title":"Front. Immunol."},{"key":"58328_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.virol.2013.09.003","volume":"447","author":"H Song","year":"2013","unstructured":"Song, H. et al. Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques. Virology 447, 181\u2013186 (2013).","journal-title":"Virology"},{"key":"58328_CR29","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.4049\/jimmunol.1200799","volume":"189","author":"J Goulding","year":"2012","unstructured":"Goulding, J., Bogue, R., Tahiliani, V., Croft, M. & Salek-Ardakani, S. CD8 T cells are essential for recovery from a respiratory vaccinia virus infection. J. Immunol. 189, 2432\u20132440 (2012).","journal-title":"J. Immunol."},{"key":"58328_CR30","doi-asserted-by":"publisher","first-page":"13980","DOI":"10.1073\/pnas.0506768102","volume":"102","author":"C Oseroff","year":"2005","unstructured":"Oseroff, C. et al. HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc. Natl. Acad. Sci. USA 102, 13980\u201313985 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58328_CR31","doi-asserted-by":"publisher","first-page":"8431","DOI":"10.4049\/jimmunol.175.12.8431","volume":"175","author":"CL Smith","year":"2005","unstructured":"Smith, C. L. et al. Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara. J. Immunol. 175, 8431\u20138437 (2005).","journal-title":"J. Immunol."},{"key":"58328_CR32","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1016\/j.vaccine.2009.05.077","volume":"27","author":"SR Walsh","year":"2009","unstructured":"Walsh, S. R. et al. Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques. Vaccine 27, 4990\u20135000 (2009).","journal-title":"Vaccine"},{"key":"58328_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1084\/jem.20041912","volume":"201","author":"DC Tscharke","year":"2005","unstructured":"Tscharke, D. C. et al. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201, 95\u2013104 (2005).","journal-title":"J. Exp. Med."},{"key":"58328_CR34","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.4049\/jimmunol.175.8.5504","volume":"175","author":"V Pasquetto","year":"2005","unstructured":"Pasquetto, V. et al. HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J. Immunol. 175, 5504\u20135515 (2005).","journal-title":"J. Immunol."},{"key":"58328_CR35","doi-asserted-by":"publisher","first-page":"6318","DOI":"10.1128\/JVI.00427-06","volume":"80","author":"DC Tscharke","year":"2006","unstructured":"Tscharke, D. C. et al. Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB\/c mice. J. Virol. 80, 6318\u20136323 (2006).","journal-title":"J. Virol."},{"key":"58328_CR36","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nbt1215","volume":"24","author":"M Moutaftsi","year":"2006","unstructured":"Moutaftsi, M. et al. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat. Biotechnol. 24, 817\u2013819 (2006).","journal-title":"Nat. Biotechnol."},{"key":"58328_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/eji.200838815","volume":"39","author":"M Moutaftsi","year":"2009","unstructured":"Moutaftsi, M. et al. Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model. Eur. J. Immunol. 39, 717\u2013722 (2009).","journal-title":"Eur. J. Immunol."},{"key":"58328_CR38","doi-asserted-by":"publisher","first-page":"105668","DOI":"10.1016\/j.antiviral.2023.105668","volume":"216","author":"H Xia","year":"2023","unstructured":"Xia, H., He, Y. R., Zhan, X. Y. & Zha, G. F. Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice. Antivir. Res. 216, 105668 (2023).","journal-title":"Antivir. Res."},{"key":"58328_CR39","doi-asserted-by":"publisher","first-page":"9844","DOI":"10.1128\/JVI.76.19.9844-9855.2002","volume":"76","author":"D Boulanger","year":"2002","unstructured":"Boulanger, D. et al. Identification and characterization of three immunodominant structural proteins of fowlpox virus. J. Virol. 76, 9844\u20139855 (2002).","journal-title":"J. Virol."},{"key":"58328_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-023-01699-8","volume":"21","author":"A Xia","year":"2023","unstructured":"Xia, A. et al. Cross-reactive antibody response to monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history. BMC Biol. 21, 205 (2023).","journal-title":"BMC Biol."},{"key":"58328_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virol.2008.04.003","volume":"377","author":"JW Golden","year":"2008","unstructured":"Golden, J. W. & Hooper, J. W. Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine. Virology 377, 19\u201329 (2008).","journal-title":"Virology"},{"key":"58328_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3201\/eid2002.130118","volume":"20","author":"JR Kugelman","year":"2014","unstructured":"Kugelman, J. R. et al. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo. Emerg. Infect. Dis. 20, 232\u2013239 (2014).","journal-title":"Emerg. Infect. Dis."},{"key":"58328_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","volume":"509","author":"SN Shchelkunov","year":"2001","unstructured":"Shchelkunov, S. N. et al. Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett. 509, 66\u201370 (2001).","journal-title":"FEBS Lett."},{"key":"58328_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/viro.2002.1446","volume":"297","author":"SN Shchelkunov","year":"2002","unstructured":"Shchelkunov, S. N. et al. Analysis of the monkeypox virus genome. Virology 297, 172\u2013194 (2002).","journal-title":"Virology"},{"key":"58328_CR45","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","volume":"177","author":"JM Heraud","year":"2006","unstructured":"Heraud, J. M. et al. Subunit recombinant vaccine protects against monkeypox. J. Immunol. 177, 2552\u20132564 (2006).","journal-title":"J. Immunol."},{"key":"58328_CR46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.virol.2007.09.029","volume":"371","author":"P Sakhatskyy","year":"2008","unstructured":"Sakhatskyy, P. et al. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens. Virology 371, 98\u2013107 (2008).","journal-title":"Virology"},{"key":"58328_CR47","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1016\/j.vaccine.2008.04.017","volume":"26","author":"JW Golden","year":"2008","unstructured":"Golden, J. W., Josleyn, M. D. & Hooper, J. W. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies. Vaccine 26, 3507\u20133515 (2008).","journal-title":"Vaccine"},{"key":"58328_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.icb.7100118","volume":"86","author":"V Panchanathan","year":"2008","unstructured":"Panchanathan, V., Chaudhri, G. & Karupiah, G. Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol. Cell Biol. 86, 80\u201386 (2008).","journal-title":"Immunol. Cell Biol."},{"key":"58328_CR49","doi-asserted-by":"publisher","first-page":"e1000768","DOI":"10.1371\/journal.ppat.1000768","volume":"6","author":"RH Xu","year":"2010","unstructured":"Xu, R. H., Remakus, S., Ma, X., Roscoe, F. & Sigal, L. J. Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response. PLoS Pathog. 6, e1000768 (2010).","journal-title":"PLoS Pathog."},{"key":"58328_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38751-8","volume":"14","author":"W Tai","year":"2023","unstructured":"Tai, W. et al. An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants. Nat. Commun. 14, 2962 (2023).","journal-title":"Nat. Commun."},{"key":"58328_CR51","doi-asserted-by":"publisher","first-page":"109107","DOI":"10.1016\/j.celrep.2021.109107","volume":"35","author":"F Gambino Jr","year":"2021","unstructured":"Gambino, F. Jr. et al. A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage. Cell Rep. 35, 109107 (2021).","journal-title":"Cell Rep."},{"key":"58328_CR52","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1038\/s41423-021-00784-8","volume":"18","author":"X Jin","year":"2021","unstructured":"Jin, X. et al. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8(+) T cell responses in HLA-A transgenic mice. Cell Mol. Immunol. 18, 2588\u20132608 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"58328_CR53","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.2147\/IJN.S367494","volume":"17","author":"AR Shen","year":"2022","unstructured":"Shen, A. R. et al. Exosomal vaccine loading T cell epitope peptides of SARS-CoV-2 induces robust CD8(+) T cell response in HLA-A transgenic mice. Int. J. Nanomed. 17, 3325\u20133341 (2022).","journal-title":"Int. J. Nanomed."},{"key":"58328_CR54","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","volume":"53","author":"AP Ferretti","year":"2020","unstructured":"Ferretti, A. P. et al. Unbiased screens show CD8(+) T Cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity 53, 1095\u20131107.e1093 (2020).","journal-title":"Immunity"},{"key":"58328_CR55","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2019.07.009","volume":"178","author":"T Kula","year":"2019","unstructured":"Kula, T. et al. T-Scan: a genome-wide method for the systematic discovery of T cell epitopes. Cell 178, 1016\u20131028.e1013 (2019).","journal-title":"Cell"},{"key":"58328_CR56","doi-asserted-by":"publisher","first-page":"109708","DOI":"10.1016\/j.celrep.2021.109708","volume":"36","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Profiling CD8(+) T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants. Cell Rep. 36, 109708 (2021).","journal-title":"Cell Rep."},{"key":"58328_CR57","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa2107058","volume":"385","author":"MG Thompson","year":"2021","unstructured":"Thompson, M. G. et al. Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. N. Engl. J. Med. 385, 320\u2013329 (2021).","journal-title":"N. Engl. J. Med."},{"key":"58328_CR58","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","volume":"187","author":"EM Mucker","year":"2024","unstructured":"Mucker, E. M. et al. Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates. Cell 187, 5540\u20135553.e5510 (2024).","journal-title":"Cell"},{"key":"58328_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","volume":"239","author":"B Moss","year":"2011","unstructured":"Moss, B. Smallpox vaccines: targets of protective immunity. Immunol. Rev. 239, 8\u201326 (2011).","journal-title":"Immunol. Rev."},{"key":"58328_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54909-4","volume":"15","author":"Q Ye","year":"2024","unstructured":"Ye, Q. et al. A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates. Nat. Commun. 15, 10611 (2024).","journal-title":"Nat. Commun."},{"key":"58328_CR61","doi-asserted-by":"publisher","first-page":"114269","DOI":"10.1016\/j.celrep.2024.114269","volume":"43","author":"T Ye","year":"2024","unstructured":"Ye, T. et al. Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus. Cell Rep. 43, 114269 (2024).","journal-title":"Cell Rep."},{"key":"58328_CR62","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.ymthe.2024.04.028","volume":"32","author":"J Zhou","year":"2024","unstructured":"Zhou, J. et al. Circular RNA vaccines against monkeypox virus provide potent protection against vaccinia virus infection in mice. Mol. Ther. 32, 1779\u20131789 (2024).","journal-title":"Mol. Ther."},{"key":"58328_CR63","doi-asserted-by":"publisher","first-page":"105392","DOI":"10.1016\/j.ebiom.2024.105392","volume":"109","author":"T Kong","year":"2024","unstructured":"Kong, T. et al. Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus. EBioMedicine 109, 105392 (2024).","journal-title":"EBioMedicine"},{"key":"58328_CR64","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2447619","volume":"14","author":"E Li","year":"2025","unstructured":"Li, E. et al. An mpox quadrivalent mRNA vaccine elicits sustained and protective immunity in mice against lethal vaccinia virus challenge. Emerg. Microbes Infect. 14, 2447619 (2025).","journal-title":"Emerg. Microbes Infect."},{"key":"58328_CR65","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s11427-023-2378-x","volume":"66","author":"N Zhang","year":"2023","unstructured":"Zhang, N. et al. Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity. Sci. China Life Sci. 66, 2329\u20132341 (2023).","journal-title":"Sci. China Life Sci."},{"key":"58328_CR66","doi-asserted-by":"publisher","unstructured":"Traut, C. C. et al. Orthopoxvirus-specific T cell responses in convalescent MPOX patients. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiad245 (2023).","DOI":"10.1093\/infdis\/jiad245"},{"key":"58328_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34655-1","volume":"13","author":"H Ogura","year":"2022","unstructured":"Ogura, H. et al. Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19. Nat. Commun. 13, 7063 (2022).","journal-title":"Nat. Commun."},{"key":"58328_CR68","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1098\/rstb.2000.0643","volume":"355","author":"D Wodarz","year":"2000","unstructured":"Wodarz, D. & Nowak, M. A. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355, 1059\u20131070 (2000).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"58328_CR69","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","volume":"75","author":"JA Wilson","year":"2001","unstructured":"Wilson, J. A. & Hart, M. K. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein. J. Virol. 75, 2660\u20132664 (2001).","journal-title":"J. Virol."},{"key":"58328_CR70","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1172\/JCI60660","volume":"122","author":"S Iborra","year":"2012","unstructured":"Iborra, S. et al. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J. Clin. Investig. 122, 1628\u20131643 (2012).","journal-title":"J. Clin. Investig."},{"key":"58328_CR71","doi-asserted-by":"publisher","first-page":"113609","DOI":"10.1016\/j.celrep.2023.113609","volume":"43","author":"M Li","year":"2024","unstructured":"Li, M. et al. Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population. Cell Rep. 43, 113609 (2024).","journal-title":"Cell Rep."},{"key":"58328_CR72","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","volume":"172","author":"R Xu","year":"2004","unstructured":"Xu, R., Johnson, A. J., Liggitt, D. & Bevan, M. J. Cellular and humoral immunity against vaccinia virus infection of mice. J. Immunol. 172, 6265\u20136271 (2004).","journal-title":"J. Immunol."},{"key":"58328_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.coviro.2017.10.001","volume":"28","author":"SJ Hobbs","year":"2018","unstructured":"Hobbs, S. J., Osborn, J. F. & Nolz, J. C. Activation and trafficking of CD8(+) T cells during viral skin infection: immunological lessons learned from vaccinia virus. Curr. Opin. Virol. 28, 12\u201319 (2018).","journal-title":"Curr. Opin. Virol."},{"key":"58328_CR74","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.chom.2023.04.015","volume":"31","author":"S Adamo","year":"2023","unstructured":"Adamo, S. et al. Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox. Cell Host Microbe 31, 928\u2013936.e924 (2023).","journal-title":"Cell Host Microbe"},{"key":"58328_CR75","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1080\/07391102.2023.2226733","volume":"42","author":"W Ezzemani","year":"2024","unstructured":"Ezzemani, W. et al. Identification of novel T-cell epitopes on monkeypox virus and development of multi-epitopes vaccine using immunoinformatics approaches. J. Biomol. Struct. Dyn. 42, 5349\u20135364 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"58328_CR76","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00465-24","volume":"12","author":"C Yu","year":"2024","unstructured":"Yu, C. et al. Designing a smallpox B-cell and T-cell multi-epitope subunit vaccine using a comprehensive immunoinformatics approach. Microbiol Spectr. 12, e0046524 (2024).","journal-title":"Microbiol Spectr."},{"key":"58328_CR77","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","volume":"603","author":"R Keeton","year":"2022","unstructured":"Keeton, R. et al. T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature 603, 488\u2013492 (2022).","journal-title":"Nature"},{"key":"58328_CR78","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","volume":"185","author":"A Tarke","year":"2022","unstructured":"Tarke, A. et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell 185, 847\u2013859.e811 (2022).","journal-title":"Cell"},{"key":"58328_CR79","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"58328_CR80","doi-asserted-by":"publisher","first-page":"110725","DOI":"10.1016\/j.intimp.2023.110725","volume":"123","author":"M Farzan","year":"2023","unstructured":"Farzan, M. et al. Immunoinformatics-based multi-epitope vaccine design for the re-emerging monkeypox virus. Int. Immunopharmacol. 123, 110725 (2023).","journal-title":"Int. Immunopharmacol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58328-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58328-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58328-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T05:12:54Z","timestamp":1743311574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58328-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58328"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58328-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent application has been filed for the antigens presented here. G.C., W.T., H.S., C.T., and B.C. are inventors. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2971"}}